Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia

From marker rescue, sequencing, transcript, and latency analyses of the thymidine kinase-negative herpes simplex virus mutant dlsactk and studies using the thymidine kinase inhibitor Ro 31-5140, we infer that the virus-encoded thymidine kinase is required in murine trigeminal ganglia for acute replication and lytic gene expression, for increasing the numbers of cells expressing latency-associated transcripts, and for reactivation from latent infection.

[1]  D. Coen,et al.  Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons , 1993, Journal of virology.

[2]  K. Wobbe,et al.  Unusual regulation of expression of the herpes simplex virus DNA polymerase gene , 1993, Journal of virology.

[3]  J. D. Karkas,et al.  Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes , 1992, Antimicrobial Agents and Chemotherapy.

[4]  C. Crumpacker,et al.  Resistance of herpesviruses to antiviral drugs , 1992, Antimicrobial Agents and Chemotherapy.

[5]  B. Keith,et al.  Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template , 1991, Journal of virology.

[6]  Y. Cheng,et al.  Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys. , 1991, Antiviral research.

[7]  D. Coen,et al.  Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site , 1991, Molecular and cellular biology.

[8]  I. Duncan,et al.  Design of Inhibitors of Herpes Simplex Virus Thymidine Kinase , 1991 .

[9]  K. Steffy,et al.  Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene , 1991, Journal of virology.

[10]  A. Papavassiliou,et al.  Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly , 1991, Journal of virology.

[11]  D. Coen,et al.  Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses , 1990, Journal of virology.

[12]  S. Czelusniak,et al.  Effect of a thymidine kinase inhibitor (L-653,180) on antiviral treatment of experimental herpes simplex virus infection in mice. , 1990, Antiviral research.

[13]  D. Coen,et al.  Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants , 1990, Journal of virology.

[14]  B. Roizman,et al.  In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus). , 1990, The Journal of infectious diseases.

[15]  J. D. Karkas,et al.  Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro , 1990, Antimicrobial Agents and Chemotherapy.

[16]  P. Schaffer,et al.  Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia , 1990, Antimicrobial Agents and Chemotherapy.

[17]  H. Balfour,et al.  Herpes Simplex Virus Resistant to Acyclovir: A Study in a Tertiary Care Center , 1990 .

[18]  K. Tyler,et al.  Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? , 1989, Annals of internal medicine.

[19]  R. Sandri-Goldin,et al.  Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus , 1989, Journal of virology.

[20]  K. Tyler,et al.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Tenser,et al.  Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1 , 1989, Journal of virology.

[22]  A. Minson,et al.  The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. , 1989, The Journal of general virology.

[23]  D. Coen,et al.  A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture , 1989, Journal of virology.

[24]  K. Tyler,et al.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency , 1989, Journal of virology.

[25]  D. Coen,et al.  Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. , 1989, Virology.

[26]  E. Mocarski,et al.  Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. , 1988, Virology.

[27]  R. Longnecker,et al.  In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. , 1988, The Journal of infectious diseases.

[28]  R. Tenser,et al.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation , 1987, Journal of virology.

[29]  R. Everett,et al.  The control of herpes simplex virus type-1 late gene transcription: a 'TATA-box'/cap site region is sufficient for fully efficient regulated activity. , 1986, Nucleic acids research.

[30]  F. Homa,et al.  Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA , 1986, Molecular and cellular biology.

[31]  R. Tenser,et al.  Thymidine kinase (TK) activity in herpes simplex virus type 1 recombinants that carry insertions affecting regulation of the TK gene. , 1986, Virology.

[32]  S. McKnight,et al.  A genetic approach to promoter recognition during trans induction of viral gene expression. , 1986, Science.

[33]  B. Roizman,et al.  Establishment of latency in mice by herpes simplex virus 1 recombinants that carry insertions affecting regulation of the thymidine kinase gene , 1985, Journal of virology.

[34]  D. Coen,et al.  Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus , 1985, Journal of virology.

[35]  J. Bienenstock,et al.  Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2 , 1984, Journal of virology.

[36]  R. Price,et al.  Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity , 1981, Infection and immunity.

[37]  R. Tenser,et al.  Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. , 1981, Virology.

[38]  S. Mackem,et al.  Regulation of α genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with α gene promoters , 1981, Cell.

[39]  J. Clements,et al.  The association of herpes simplex virus with squamous carcinoma of the cervix, and studies of the virus thymidine kinase gene , 1980, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[40]  R. Tenser,et al.  Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. , 1979, Virology.

[41]  S. Bacchetti,et al.  Selective assay for herpes simplex viruses expressing thymidine kinase , 1979, Journal of virology.

[42]  P. Schaffer,et al.  Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2 , 1978, Journal of virology.

[43]  K. Nadeau,et al.  The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Tenser Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency. , 1991, Intervirology.

[45]  I. Duncan,et al.  New Potent and Selective Inhibitors of Herpes Simplex Virus Tbyhidine Kinase , 1989 .

[46]  V. Rich Personal communication , 1989, Nature.

[47]  R. Longnecker,et al.  Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. , 1988, Virology.

[48]  B. Roizman,et al.  An inquiry into the mechanisms of herpes simplex virus latency. , 1987, Annual review of microbiology.